Steve Aselage Acer Therapeutics Inc. (ACER) insider trading activity

ACER Quotes by TradingView

Steve Aselage is Director of Acer Therapeutics Inc.. Currently has a direct ownership of 0 shares of ACER, which is worth approximately $0. The most recent transaction as insider was on Nov 17, 2023, when has been sold 483,741 shares (Common Stock, $0.0001 par value per share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

STEVE ASELAGE Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 17 2023
SELL
Sale (or disposition) back to the issuer
-
483,741 Reduced 100.0%
0 Common Stock, $0.0001 ...
Nov 29 2022
BUY
Open market or private purchase
$499,999 $1.22 p/Share
409,836 Added 45.86%
483,741 Common Stock
Dec 10 2021
BUY
Open market or private purchase
$16,287 $2.04 p/Share
7,984 Added 9.75%
73,905 Common Stock
Dec 09 2021
BUY
Open market or private purchase
$4,334 $2.15 p/Share
2,016 Added 2.97%
65,921 Common Stock

Also insider at

TVTX
Travere Therapeutics, Inc. Healthcare
Director
BCRX
BIOCRYST PHARMACEUTICALS INC Healthcare
Director
SA

Steve Aselage

Director
Durham, NC

Track Institutional and Insider Activities on ACER

Follow Acer Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ACER shares.

Notify only if

Insider Trading

Get notified when an Acer Therapeutics Inc. insider buys or sells ACER shares.

Notify only if

News

Receive news related to Acer Therapeutics Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ACER